🟢 HCW Biologics is trading 10.80% up in after-hours trading despite no identified company-specific announcement

HCW Biologics is trading 10.80% up at $2.36 in after-hours trading, with no new company-specific announcement identified during the session.

• Closed at $2.13 on August 18, 2026; the broader market was risk-off that day.
• The latest earnings update highlighted a wider $5.2 million quarterly loss and only $741,324 in cash.
• It also raised substantial doubt about continuing operations without additional funding.